Clinical Trials Browser

Recruiting × Perivascular Epithelioid Cell Neoplasms × pembrolizumab × Clear all

NCT07089992 2026-05-14

A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Phase 2 Recruiting

Liposarcoma, Sarcoma, Perivascular Epithelioid Cell Neoplasms